Hutchin Hill Capital’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-17,100
Closed -$1.37M 1116
2017
Q1
$1.37M Buy
+17,100
New +$1.36M 0.04% 411
2013
Q4
Sell
-9,000
Closed -$287K 668
2013
Q3
$287K Sell
9,000
-7,650
-46% -$203K 0.03% 392
2013
Q2
$376K Buy
+16,650
New +$360K 0.04% 320

Other funds holding CMD

Hutchin Hill Capital's CMD Position: Q2 2017 in Review

Hutchin Hill Capital sold out of Cantel Medical Corporation (CMD) in Q2 2017, closing a stake of 17,100 shares — an estimated $1.37M sold.

Hutchin Hill Capital first reported a position in CMD in Q2 2013 and held it in 3 quarters. The position peaked at $1.37M in Q1 2017. 214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • Hutchin Hill Capital reported no remaining Cantel Medical Corporation position as of Q2 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 17,100 Cantel Medical Corporation shares in Q2 2017, an estimated $1.37M.
  • Hutchin Hill Capital first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 3 quarters.
  • Hutchin Hill Capital's Cantel Medical Corporation position peaked at $1.37M in Q1 2017.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on Hutchin Hill Capital's 13F filing for Q2 2017, filed 14 Aug 2017.